Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109197 · ClinicalTrials.gov registry record
Sudden Unexplained Death in Childhood (SUDC) Registry
A clinical trial of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 1,600
- Enrollment target
- 1
- Study location
NCT03109197: Recruiting study of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood, sponsored by NYU Langone Health.
NCT03109197 is a study of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 1,600 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03109197, a study of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 1,600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 18 years who have died suddenly and unexpectedly, and in some instances, without explanation. The SUDC Registry and Research Collaborative will analyze cases of sudden unexpected deaths in these children to understand risk factors and causes, and develop preventative measures.
Conditions Studied
Interventions
- OTHER Biospecimin Collection
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2028-11-30 |
What NCT03109197 shows while recruiting
NCT03109197 is an observational study that tracks outcomes without assigning an intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Sudden Unexplained Death Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Biospecimin Collection is the first listed.
NCT03109197 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03109197 about?
NCT03109197 is a clinical study titled "Sudden Unexplained Death in Childhood (SUDC) Registry". The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 18 years who have died suddenly and unexpectedly, and in some instances, without explanation. The SUDC Registry and Research Collaborative wil...
What is the current status of trial NCT03109197?
This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 2014-10-01. Estimated completion is 2028-11-30.
What conditions does trial NCT03109197 study?
This clinical trial studies the following conditions: Sudden Unexplained Death Syndrome, Sudden Unexplained Death in Childhood.
What interventions are being tested in trial NCT03109197?
The interventions under investigation include: Biospecimin Collection (OTHER).
Who is sponsoring clinical trial NCT03109197?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03109197 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
- NCT04580472 · 1,600 participants · Phase 4
Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI